Skip to main navigation Skip to search Skip to main content

Planning the human variome project: The Spain report

  • Jim Kaput
  • , Richard G.H. Cotton
  • , Lauren Hardman
  • , Michael Watson
  • , Aida I.Al Aqeel
  • , Jumana Y. Al-Aama
  • , Fahd Al-Mulla
  • , Santos Alonso
  • , Stefan Aretz
  • , Arleen D. Auerbach
  • , Bharati Bapat
  • , Inge T. Bernstein
  • , Jong Bhak
  • , Stacey L. Bleoo
  • , Helmut Blöcer
  • , Steven E. Brenner
  • , John Burn
  • , Mariona Bustamante
  • , Rita Calzone
  • , Anne Cambon-Thomsen
  • Michele Cargill, Paola Carrera, Lawrence Cavedon, Yoon Shin Cho, Yeun Jun Chung, Mireille Claustres, Garry Cutting, Raymond Dalgleish, Johan T.Den Dunnen, Carlos Díaz, Steven Dobrowolski, M. Rosário N.Dos Santos, Rosemary Ekong, Simon B. Flanagan, Paul Flicek, Yoichi Furukawa, Maurizio Genuardi, Ho Ghang, Maria V. Golubenko, Marc S. Greenblatt, Ada Hamosh, John M. Hancock, Ross Hardison, Terence M. Harrison, Robert Hoffmann, Rania Horaitis, Heather J. Howard, Carol Isaacson Barash, Neskuts Izagirre, Jongsun Jung, Toshio Kojima, Sandrine Laradi, Yeon Su Lee, Jong Young Lee, Vera L. Gil-da-Silva-Lopes, Finlay A. Macrae, Donna Maglott, Makia J. Marafie, Steven G.E. Marsh, Yoichi Matsubara, Ludwine M. Messiaen, Gabriela Möslein, Mihai G. Netea, Melissa L. Norton, Peter J. Oefner, William S. Oetting, James C. O'Leary, Ana Maria Oller De Ramirez, Mark H. Paalman, Jillian Parboosingh, George P. Patrinos, Giuditta Perozzi, Ian R.Phillips, Sue Povey, Suyash Prasad, Ming Qi, David J. Quin, Rajkumar S. Ramesar, C. Sue Richards, Judith Savige, Dagmar G. Scheible, Rodney J. Scott, Daniela Seminara, Elizabeth A. Shephard, Rolf H. Sijmons, Timothy D. Smith, María Jesús Sobrido, Toshihiro Tanaka, Sean V. Tavtigian, Graham R. Taylor, Jon Teague, Thoralf Töpel, Mollie Ullman-Cullere, Joji Utsunomiya, Henk J. Van Kranen, Mauno Vihinen, Elizabeth Webb, Thomas K. Weber, Meredith Yeager, Young I. Yeom, Seon Hee Yim, Hyang Sook Yoo
  • United States Food and Drug Administration
  • Genomic Disorders Research Centre
  • University of Melbourne
  • American College of Medical Genetics
  • Prince Sultan Military Medical City
  • King Abdulaziz University
  • Kuwait University
  • University of the Basque Country
  • University of Bonn
  • Rockefeller University
  • University of Toronto
  • University of Copenhagen
  • Korea Research Institute of Bioscience and Biotechnology
  • University of Alberta
  • Helmholtz Centre for Infection Research
  • University of California at Berkeley
  • International Centre for Life
  • Department of Cell and Developmental Biology
  • Genetic Service ASL
  • Institut national de la santé et de la recherche médicale
  • Navigenics, Inc.
  • Division of Genetics and Cell Biology
  • CSIRO
  • Korea National Institute of Health
  • CHU Montpellier
  • Johns Hopkins University
  • University of Leicester
  • Leiden University
  • Municipal Institute for Medical Research Hospital del Mar
  • BioMerieux
  • Instituto Nacional de Saúde Doutor Ricardo Jorge
  • University College London
  • Royal Brisbane and Women's Hospital
  • Wellcome Trust
  • The University of Tokyo
  • University of Florence
  • Institute of Medical Genetics
  • University of Vermont
  • Bioinformatics Group
  • Pennsylvania State University
  • Royal Melbourne Hospital
  • Massachusetts Institute of Technology
  • Ethics and Policy Consulting Inc.
  • RIKEN
  • Establissement Francais du Sang
  • National Cancer Center Korea
  • Universidade Estadual de Campinas
  • OMIM
  • Kuwait Medical Genetics Centre
  • Tohoku University
  • University of Alabama at Birmingham
  • Fresenius AG
  • Radboud University Nijmegen
  • Genome Medicine
  • University of Regensburg
  • University of Minnesota Twin Cities
  • Genetic Alliance
  • Universidad Nacional de Córdoba
  • Human Mutation
  • University of Calgary
  • Erasmus University Rotterdam
  • Council for Agricultural Research and Economics
  • Queen Mary University of London
  • Genzyme Therapeutics Ltd
  • First Affiliated Hospital of Zhejiang University
  • University of Rochester
  • Department of Human Services
  • University of Cape Town
  • Oregon Health and Science University
  • University of Melbourne
  • Klinik fuer Kinder-und Jugendmedizin
  • University of Newcastle
  • National Institutes of Health
  • University of Groningen
  • Santiago de Compostela
  • Instituto de Salud Carlos III
  • International Agency for Research on Cancer
  • Cancer Research
  • Wellcome Sanger Institute
  • Bielefeld University
  • Harvard University
  • National Institute of Public Health and the Environment
  • Tampere University
  • Albert Einstein College of Medicine
  • The Catholic University of Korea

Research output: Contribution to journalReview articlepeer-review

44 Scopus citations

Abstract

The remarkable progress in characterizing the human genome sequence, exemplified by the Human Genome Project and the HapMap Consortium, has led to the perception that knowledge and the tools (e.g., micro-arrays) are sufficient for many if not most biomedical research efforts. A large amount of data from diverse studies proves this perception inaccurate at best, and at worst, an impediment for further efforts to characterize the variation in the human genome. Because variation in genotype and environment are the fundamental basis to understand phenotypic variability and heritability at the population level, identifying the range of human genetic variation is crucial to the development of personalized nutrition and medicine. The Human Variome Project (HVP; http://www.humanvariomeproject.org/) was proposed initially to systematically collect mutations that cause human disease and create a cyber infrastructure to link locus specific databases (LSDB). We report here the discussions and recommendations from the 2008 HVP planning meeting held in San Feliu de Guixols, Spain, in May 2008.

Original languageEnglish
Pages (from-to)496-510
Number of pages15
JournalHuman Mutation
Volume30
Issue number4
DOIs
StatePublished - Apr 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Database
  • Genetic disease
  • Genome
  • Mutation
  • Variome

Fingerprint

Dive into the research topics of 'Planning the human variome project: The Spain report'. Together they form a unique fingerprint.

Cite this